1. |
Diel R, Loddenkemper R, Meywald-Walter K, et al. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med, 2008, 177(10):1164-1170.
|
2. |
张丽帆, 刘晓清. γ干扰素释放分析T-SPOT.TB诊断结核感染临床应用进展.中国医学科学院学报, 2009, 31(4):506-510.
|
3. |
Baum GL, Wu JN, Hua SS, et al. Skin sensitivity to histolyn, spherulin, and PPD in the People's Republic of China. Chest, 1990, 97(6): 1356-1359.
|
4. |
Brock I, Weldingh K, Lillebaek T, et al. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med, 2004, 170(1):65-69.
|
5. |
Simsek H, Alpar S, Ucar N, et al. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis. Jpn J Infect Dis, 2010, 63(2):99-102.
|
6. |
Turtle L, Kemp T, Davies GR, et al. In routine UK hospital practice T-SPOT.TB is useful in some patients with a modest pre-test probability of active tuberculosis. Eur J Intern Med, 2012, 23(4):363-367.
|
7. |
Feng Y, Diao N, Shao L, et al. Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis. PLoS One, 2012, 7(3):e32652.
|
8. |
Lai CC, Tan CK, Lin SH, et al. Diagnostic performance of wholeblood interferon-gamma assay and enzyme-linked immunospot assay for active tuberculosis. Diagn Microbiol Infect Dis, 2011, 71(2): 139-143.
|
9. |
Boyd AE, Ashcroft A, Lipman M, et al. Limited added value of TSPOT.TB blood test in diagnosing active TB:a prospective bayesian analysis. J Infect, 2011, 62(6):456-461.
|
10. |
Kim SH, Choi SJ, Kim HB, et al. Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis. Arch Intern Med, 2007, 167(20):2255-2259.
|
11. |
霍霏霏, 张丽帆, 刘晓清.评价γ干扰素释放分析T-SPOT.TB在肺外结核病诊断中的敏感性.中国医学科学院学报, 2009, 31(4): 449-452.
|
12. |
Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis:a systematic review and meta-analysis. Lancet Infect Dis, 2012, 12(1): 45-55.
|
13. |
Chee CB, Gan SH, Khinmar KW, et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol, 2008, 46(6):1935-1940.
|
14. |
Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J, 2006, 28(1):24-30.
|
15. |
Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science, 1999, 284(5419):1520-1523.
|
16. |
Pai M. Alternatives to the tuberculin skin test:interferon-gamma assays in the diagnosis of mycobacterium tuberculosis infection. Indian J Med Microbiol, 2005, 23(3):151-158.
|
17. |
Dai Y, Feng Y, Xu R, et al. Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis:an updated meta-analysis. Eur J Clin Microbiol Infect Dis, 2012, 31(11):3127-3137.
|
18. |
Yu Y, Zhao X, Wang W, et al. Diagnostic performance of interferongamma releasing assay in HIV-infected patients in China. PLoS One, 2013, 8(8):e70957.
|
19. |
Santin M, Munoz L, Rigau D. Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIVinfected adults:a systematic review and meta-analysis. PLoS One, 2012, 7(3):e32482.
|
20. |
Kim HJ, Yoon HI, Park KU, et al. The impact of previous tuberculosis history on T-SPOT.TB(R) interferon-gamma release assay results. Int J Tuberc Lung Dis, 2011, 15(4):510-516.
|
21. |
Lee YM, Park KH, Kim SM, et al. Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis. Infection, 2013, 41(6):1089-1095.
|